Trending
VanEck’s Pharma ETF offers lower costs and stability; Invesco’s Biotech ETF chases higher returns with steeper risk. Which fits your portfolio?
Trump’s vaccine executive order is raising alarms among pediatricians as measles spreads, immunization rates fall, and children return to school.
On Holding cut its full-year sales outlook, missing expectations and sending shares lower premarket. Roger Federer’s equity stake fell with the stock.
Tesla is recalling 20,349 U.S. vehicles over low-beam headlights that may be too bright, posing a crash risk to oncoming drivers, per NHTSA.
Boston Scientific director Habiger bought $100K in BSX shares, expanding his stake 14% as the stock sits near a 54% decline and multi-year lows.
Clothing retailers are offering repairs and sewing workshops to attract Gen Z shoppers motivated by both saving money and reducing environmental waste.
Tesla is recalling 20,349 U.S. vehicles over low-beam headlights that may be too bright, posing a crash risk to oncoming drivers, per NHTSA.
Maruti Suzuki Chairman R.C. Bhargava projects India’s passenger vehicle market reaching 6.1-6.3 million units by fiscal 2030-31, citing small car revival and SUV growth.
Just In
On Holding cut its full-year sales outlook, missing expectations and sending shares lower premarket. Roger Federer’s equity stake fell with the stock.
Trump’s vaccine executive order is raising alarms among pediatricians as measles spreads, immunization rates fall, and children return to school.
Clothing retailers are offering repairs and sewing workshops to attract Gen Z shoppers motivated by both saving money and reducing environmental waste.
The U.S. Senate passed a resolution adding Missouri to the 1960 college football national title claimants, raising questions about legislative resources and athletic prestige economics.
The U.S. suspended all operations in Michoacan over an unspecified security threat, halting avocado inspections needed for exports to American markets.
Finance
VanEck’s Pharma ETF offers lower costs and stability; Invesco’s Biotech ETF chases higher returns with steeper risk. Which fits your portfolio?
Editor's Picks
Latest
Andromeda Capital Management warns AI credit markets offer “almost no upside and plenty of downside” as ROI on massive AI capex remains unresolved.

































